March 23, 2023

Volume XIII, Number 82

Advertisement
Advertisement

March 22, 2023

Subscribe to Latest Legal News and Analysis

March 21, 2023

Subscribe to Latest Legal News and Analysis

March 20, 2023

Subscribe to Latest Legal News and Analysis
Advertisement

Podcast: Post-Dobbs: Considerations for Clinical Trials and Research – Diagnosing Health Care

In this episode of the Diagnosing Health Care Podcast:   The Dobbs v. Jackson Women’s Health Organization decision, which effectively removed the federal constitutional protections for abortion, triggered a series of changes for health care providers and patients alike across the nation with respect to abortion services.

What additional implications are there for certain aspects of clinical trials and research?

On this episode, Epstein Becker Green attorneys Kate Heffernan, Marylana Helou, and Megan Robertson discuss how the changing state laws and regulations post-Dobbs may impact clinical research in different ways for different stakeholders.

 

 

The Diagnosing Health Care podcast series examines the business opportunities and solutions that exist despite the high-stakes legal, policy, and regulatory issues that the health care industry faces. Subscribe on your favorite podcast platform.

©2023 Epstein Becker & Green, P.C. All rights reserved.National Law Review, Volume XIII, Number 26
Advertisement
Advertisement
Advertisement

About this Author

Epstein Becker Green has served as a thought leader in the health care industry for more than 40 years. Our attorneys guide clients through complex litigation, corporate transactions, government investigations, FDA and regulatory compliance, privacy and security law, and more.

Health care is in our genes. The breadth of experience delivered by our Health Care and Life Sciences practice—to all players throughout every sector of the health care delivery system—sets us apart. We know the industry inside and out. You might say, it’s in our genes.

312.499.1421